MustGrow Biologics (MGRO) Financial Statements

19 Followers

MustGrow Biologics Financial Overview

MustGrow Biologics's market cap is currently C$33.55M. The company's EPS TTM is C$; its P/E ratio is -3.66; MustGrow Biologics is scheduled to report earnings on April 23, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 24	Mar 23	Mar 22	Dec 20
Income Statement
Total Revenue	C$ 398.02K	C$ 4.71M	C$ 6.48K	C$ 12.87K	C$ 0.00
Gross Profit	C$ 300.75K	C$ 4.33M	C$ 6.48K	C$ 12.87K	C$ 0.00
Operating Income	C$ -5.11M	C$ -804.99K	C$ -5.56M	C$ -3.01M	C$ -3.37M
EBITDA	C$ -5.11M	C$ -676.94K	C$ -5.56M	C$ -3.01M	C$ -3.26M
Net Income	C$ -4.89M	C$ -676.94K	C$ -5.57M	C$ -3.06M	C$ -3.36M
Balance Sheet
Cash & Short-Term Investments	C$ 3.00M	C$ 6.82M	C$ 7.02M	C$ 9.62M	C$ 3.31M
Total Assets	C$ 5.42M	C$ 6.94M	C$ 7.13M	C$ 9.70M	C$ 3.37M
Total Debt	C$ 517.99K	C$ 759.33K	C$ 759.33K	C$ 749.27K	C$ 902.24K
Net Debt	C$ -2.48M	C$ -6.06M	C$ -6.26M	C$ -8.87M	C$ -2.41M
Total Liabilities	C$ 3.25M	C$ 1.35M	C$ 1.90M	C$ 1.25M	C$ 1.05M
Stockholders' Equity	C$ 2.17M	C$ 5.58M	C$ 5.24M	C$ 8.46M	C$ 2.32M
Cash Flow
Free Cash Flow	C$ -3.58M	C$ -294.76K	C$ -3.26M	C$ -2.41M	C$ -2.58M
Operating Cash Flow	C$ -3.58M	C$ -294.76K	C$ -3.26M	C$ -2.41M	C$ -2.58M
Investing Cash Flow	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Financing Cash Flow	C$ -241.34K	C$ 95.75K	C$ 653.75K	C$ 8.72M	C$ 1.86M

Currency in CAD

MustGrow Biologics Earnings and Revenue History

Income Statement >

MustGrow Biologics Debt to Assets

Balance Sheet >

MustGrow Biologics Cash Flow

Cash Flow >

MustGrow Biologics Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >